Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
about
Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of TolerogenicityTrial watch: Dendritic cell-based anticancer therapyGene expression profiling of dendritic cells reveals important mechanisms associated with predisposition to Staphylococcus infectionsClassification of dendritic cell phenotypes from gene expression dataDifferential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsQuality assessment of cellular therapies: the emerging role of molecular assays.Vitamin D related genes in lung development and asthma pathogenesisMonocyte-derived DC maturation strategies and related pathways: a transcriptional viewAngiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approachesHIV-1 gp120 influences the expression of microRNAs in human monocyte-derived dendritic cells via STAT3 activationAssociation between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population.MicroRNA-155 induces differentiation of RAW264.7 cells into dendritic-like cells.Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.Helminth excreted/secreted antigens repress expression of LPS-induced Let-7i but not miR-146a and miR-155 in human dendritic cells.Dendritic cells in cancer immunotherapy clinical trials: are we making progress?Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptideRegulation of tumor immunity by tumor/dendritic cell fusionsUnderstanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.The gene expression profile of unstimulated dendritic cells can be used as a predictor of function.The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells.MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4.CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity.Trial watch: Dendritic cell-based interventions for cancer therapy.Chemokine CXCL11 links microbial stimuli to intestinal inflammation.Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.miR-181d regulates human dendritic cell maturation through NF-κB pathway.Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG.Chitotriosidase Expression during Monocyte-Derived Dendritic Cells Differentiation and Maturation.MicroRNA-155 modulates P2R signaling and Th2 priming of dendritic cells during allergic airway inflammation in mice.Immune cell profiling in cancer: molecular approaches to cell-specific identification.Identification of key genes and pathways in regulating immune‑induced diseases of dendritic cells by bioinformatic analysis.
P2860
Q26779413-A9B7CB6F-E32C-4560-9E44-CC2B044C3D0DQ27024047-AA6E024D-9FE7-4124-A327-CFA465636991Q33998838-AB533EBC-F4D2-4700-A30F-C32C35883F83Q34004943-37BAF770-1479-4278-9FF1-57DFC51EA291Q34103945-05B5FB61-65A8-4CE3-9F96-8CE68986FADCQ34316777-A572AD9D-6D42-4C69-9780-8FE2D219E4BAQ34492365-F78BDBAA-97D0-4E8C-89E2-7AABBDA6E09FQ34916497-CFC298EC-6AC5-49C8-8AD4-7E0691A1C855Q35175852-62F3ED1F-AAFC-4949-AD14-325DD2A17772Q35676143-65FCB381-D55E-4879-9073-7D7F77EF8EA2Q36420867-7840576C-910D-4312-AEA8-B6E0A45CE9A9Q36464336-058859D5-3188-47EC-8032-0EA20FF33F0FQ36511520-AD3AD5BD-2F3E-43A9-B8A1-C1EB06B0D5BBQ36665089-07292586-FA34-48D0-A423-CDC760169497Q37389096-2346AA65-5204-4D5A-A3B2-D58E4458DF86Q37520734-4288DB6B-65B4-4B67-BF3B-2F1D0B6E251FQ37806963-EDF43438-A524-42FB-8B14-78169D84ED98Q37873924-C934A410-8ABE-48F2-B996-98C95DC11BD3Q38336073-1CF65A62-994C-40CB-A38A-8A75FFE3D38BQ39566639-AA2713C6-99FD-4012-B922-0E4DFE147234Q40715358-E36AE1CE-E6A3-4914-B20A-D8E373B48FB6Q41908332-A7A81955-4DC5-49A6-B1EE-30DD7953608DQ41916538-5B6647C3-1BF1-45D9-B4A6-CD1DC52EEEE1Q42867339-62921F0E-8492-4245-84A1-79D8BF400995Q43509929-125E44CE-35F6-4A62-8ABD-82E2E3D2FD69Q47767814-32C55AC6-AD8E-4955-87BE-B38262D6CF75Q47821872-EB6BB974-C95F-441A-ACC6-F8999F94EF25Q51584617-79CE906A-ECA1-4D9D-9935-A976754A59B5Q53485533-A53C3290-6ABA-4609-B312-F1A37248129CQ53518395-F76AC52F-7BA6-4970-B080-2AA031843398Q54947687-E815979F-0D90-4431-A2FC-7AD7D9B4FEC9Q55256172-3A3CBF06-C073-44A4-8216-2CFCF88C74D7
P2860
Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular signatures of maturi ...... ty of dendritic cell therapies
@ast
Molecular signatures of maturi ...... ty of dendritic cell therapies
@en
type
label
Molecular signatures of maturi ...... ty of dendritic cell therapies
@ast
Molecular signatures of maturi ...... ty of dendritic cell therapies
@en
prefLabel
Molecular signatures of maturi ...... ty of dendritic cell therapies
@ast
Molecular signatures of maturi ...... ty of dendritic cell therapies
@en
P2093
P2860
P356
P1476
Molecular signatures of maturi ...... ty of dendritic cell therapies
@en
P2093
David F Stroncek
Francesco M Marincola
Jiaqiang Ren
Stefanie Saunders
P2860
P2888
P356
10.1186/1479-5876-8-4
P50
P577
2010-01-15T00:00:00Z
P5875
P6179
1048563985